CARMEL, Ind., Nov. 9, 2023 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company") a healthcare company addressing some of healthcare's most significant challenges by providing innovative services and technology solutions, today announced that it expects to report third quarter 2023 financial results for the period ended September 30, 2023, on November 14, 2023. The Company has scheduled a conference call on the same day, at 9:00 AM ET, to discuss the results.
Interested parties can access the conference call via Internet webcast, which is available in the Investor Relations section of the Company's website at https://ir.syrahealth.com/presentations or at https://app.webinar.net/QnrqX7vAKVL.
Investors who would like to submit a question to be addressed on the call should email the question to This email address is being protected from spambots. You need JavaScript enabled to view it..
A webcast replay will be available in the Investor Relations section of the Company's website at https://ir.syrahealth.com/presentations.
ABOUT SYRA HEALTH CORP.
Syra Health is a healthcare company addressing some of healthcare's most significant challenges by providing innovative services and technology solutions. Syra Health specializes in behavioral and mental health, digital health, and population health. Syra Health's solutions are centered on prevention, improved access, and affordable care. For more information, please visit www.syrahealth.com.
For more information, please contact:
Media:
Syra Health
Communications & Marketing Director
Christine Drury
317-385-9227
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investors:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$0.40 |
Daily Change: | 0.02 5.99 |
Daily Volume: | 55,080 |
Market Cap: | US$3.590M |
September 13, 2024 August 08, 2024 July 30, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORECompass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB